Breast Cancer Epidemiology
Research from University Hospital provide new insights into breast cancer epidemiology
Published in Women's Health Law Weekly, July 29th, 2007
New investigation results, "A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer," are detailed in a study published in Clinical Cancer Research. According to recent research published in the journal Clinical Cancer Research, "Pemetrexed has shown varied response rates in advanced breast cancer. This randomized, double-blind, phase II study was conducted to assess the efficacy and safety of two doses of pemetrexed in a homogeneous population."
"A secondary objective was to identify molecular biomarkers correlating with response and toxicity. Patients with newly diagnosed metastatic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- HIV/AIDS Prevention
Researchers from University of Medicine and Dentistry of New Jersey provide details of new studies and findings in the area of HIV/AIDS prevention - Menopause
Noven To Acquire Jds Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline - Women's Health
Breastfeeding, Childbirth and Parenting Experts Gather for La Leche League International 50th Anniversary Conference - Aging
Link between carbohydrate quality and vision loss is strengthened by new data - Anesthesia
School of Medicine, Department of Urology reports research in anesthesia - Angiogenesis
Research data from University of Kuopio, Institute of Clinical Medicine update understanding of angiogenesis - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
